Oculus Innovative Sciences, Inc. announced that Dr. Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn(TM) Technology in treating diabetic foot ulcers as compared to povidone iodine (10%) antiseptic, which is often used as the “standard care” in treatment of open wounds.
[...]
“In light of the positive evidence generated by this study,” said Dr. Dalla Paola, “my associates and I are highly enthusiastic about Microcyn’s potential to redefine the standard of treatment in diabetic foot ulcers. This study certainly warrants further examination of this super-oxidized water formula, not only in the treatment of diabetic foot ulcers, but also in dealing with other chronic wounds and burns — essentially in any wound where infection is a challenge.”
Results of Clinical Study Evaluating Treatment of Diabetic Foot Ulcers Using Microcyn(TM) Technology Presented at Stuttgart2005: 10/5/2005 9:00:00 AM EST